Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL31241400 | 0.97 | CES2 (0.39) | CES2CES1CA1CA2CA12 | |
| Iodide SCHEMBL30689240 | 0.97 | CES2 (0.39) | CES2CES1CA1CA2CA12 | |
| SCHEMBL5515689 | 0.84 | ALDH1A1 (0.36) | CES2CES1CA1CA2CA12 | |
| SCHEMBL15573666 | 0.80 | GAA (0.50) | CA1CA2CA12CA7CA13 | |
| SCHEMBL30005190 | 0.80 | CYP3A4 (0.50) | CA1CA2CA12CA7CA13 | |
| SCHEMBL29621743 | 0.80 | GAA (0.50) | CA1CA2CA12CA7CA13 | |
| SCHEMBL18373638 | 0.80 | CA1 (0.33) | CA1CA2CA12CA7CA13 | |
| SCHEMBL5511737 | 0.80 | CA1 (0.36) | CES2CES1CA1CA2CA12 | |
| SCHEMBL15573628 | 0.80 | ALDH1A1 (0.41) | CA1CA2CA12CA7CA13 | |
| SCHEMBL720468 | 0.80 | CYP3A4 (0.50) | CA1CA2CA12CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 988 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015369-A1 | PEROVSKITE SYSTEM INCLUDING ANILINIUM-BASED LIGANDS AND RELATED PEROVSKITE SOLAR CELL | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2026-01-15 | — | — | US | claimed |
| CN-119798091-A | Preparation process of 3,4, 5-trifluoroaniline | 江苏丰山生化科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119684813-A | Azo dichroism dye and preparation method and application thereof | 苏州苏凯路化学科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119546047-A | Preparation method of efficient stable perovskite solar cell combining ionic compound interface modification and polymer material external encapsulation | 西北工业大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118754797-B | Synthesis method of 3,4, 5-trifluoro-bromobenzene | 台州鸿都生物科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| EP-3796409-B1 | ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE COMPRISING SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-01-15 | — | — | EP | claimed |
| CN-119264191-A | Preparation method and application of quinoline nickel pyridine precatalyst | 山西大学 | 2025-01-07 | — | — | CN | claimed |
| CN-116410106-B | Benzamide HBV capsid protein inhibitor and preparation method and application thereof | 山东第二医科大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118637975-B | Synthesis method of 3,4, 5-trifluoro-bromobenzene | 山东国邦药业有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-3931197-A1 | PROCESS FOR THE PREPARATION OF (6S)-3-[(4S)-4-CYANO-2-OXO-PYRROLIDIN-1-YL]-6-METHYL-N-(3,4,5-TRIFLUOROPHENYL)-6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE-5-CARBOXAMIDE | F. Hoffmann-La Roche AG (CH) | 2022-01-05 | — | — | EP | claimed |
| CN-113454088-A | Process for the preparation of (6S) -3- [ (4S) -4-cyano-2-oxo-pyrrolidin-1-yl ] -6-methyl-N- (3,4, 5-trifluorophenyl) -6, 7-dihydro-4H-pyrazolo [1,5-a ] pyrazine-5-carboxamide | 豪夫迈·罗氏有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-113200956-A | Sulfabenzamide derivative and preparation method and application thereof | 潍坊医学院 | 2021-08-03 | — | — | CN | claimed |
| CN-112827368-A | Anti-pollution reverse osmosis membrane and preparation method thereof | 中化(宁波)润沃膜科技有限公司 | 2021-05-25 | — | — | CN | claimed |
| CN-108947850-B | Preparation method of 3,4, 5-trifluoroaniline | 蚌埠中实化学技术有限公司 | 2021-05-18 | — | — | CN | claimed |
| US-20170283366-A1 | Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives | UNITED ARAB EMIRATES UNIVERSITY (AE) | 2017-10-05 | — | — | US | claimed |
| CN-103204962-A | Long-chain branched isotatic polypropylene and preparation method thereof | CHINESE ACAD INST CHEMISTRY | 2013-07-17 | — | — | CN | claimed |
| CN-101891851-A | Method for preparing long chain branching isotactic polypropylene | CHINESE ACAD INST CHEMISTRY | 2010-11-24 | — | — | CN | claimed |
| EP-1461313-B1 | HUMAN ADAM-10 INHIBITORS | EXELIXIS INC (US) | 2009-08-05 | — | — | EP | claimed |
| US-20050227973-A1 | Human adam-10 inhibitors | EXELIXIS, INC. | 2005-10-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015369-A1 | PEROVSKITE SYSTEM INCLUDING ANILINIUM-BASED LIGANDS AND RELATED PEROVSKITE SOLAR CELL | BMX, ITGB3, TSNAX | CES2 1384/4885CES1 3502/4885CA1 730/4885 |
| US-20050227973-A1 | Human adam-10 inhibitors | ADAM10, ADAM12, ADAM9 | CES2 1167/4885CES1 115/4885CA1 461/4885 |
| US-20170283366-A1 | Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives | BRCA1, BBOX1, KMO | CES2 3951/4885CES1 2171/4885CA1 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.